Express Pharma June 2021 EP News Bureau Jun 1, 2021 India's Foremost Pharma & Biotech Magazine ~ Reaffirming Commitment To Sustainability
Four pharma firms get approval under PLI scheme for bulk drugs Press Trust of India May 31, 2021 Solara Active Pharma Science, Rajasthan Antibiotics, Dhatri Lab and Vital Laboratories received approval
Scientists identify drug that prevents multiple coronavirus variants Press Trust of India May 31, 2021 Findings suggest that the drug diABZI activates the body's innate immune response, the first line of defence against invading…
Generic Pharmasec signs distribution and marketing pact with Abbott Point of Care EP News Bureau May 31, 2021 Aim to increase i-STAT devices penetration by at least 1,000 additional hospital set-ups in the next 24 months by creating…
JB Chemicals launches medicated nicotine lozenges and AI-enabled Chatbot to help quit smoking EP News Bureau May 31, 2021 NOSMOK prescription medicated nicotine lozenges will be available as 2mg and 4mg lozenges in sugar-free and sugar-based variants…
Characterisation of second wave of COVID-19 in India EP News Bureau May 31, 2021 Dr Raghuvir Keni, PharmD, DST-SERB Senior Research Fellow, Department of Pharmacology, Manipal College of Pharmaceutical Sciences,…
HP India, Jubilant Bhartia Foundation introduce virtual helpdesk for Co-WIN registrations EP News Bureau May 31, 2021 The virtual helpdesk will provide assistance initially in Hindi, English, Telugu, Tamil and Kannada and will add more regional…
Modern Laboratories to produce Amphotericin B to treat black fungus ANI May 31, 2021 The price in the market will be around Rs 3,000, while we will give the government around Rs 1,500, said Anil Kharia, Chairman,…
Will be able to supply 9-10 crore doses of Covishield in June: SII Press Trust of India May 30, 2021 In early May, SII had communicated to the Centre that production of Covishield would be ramped up to 6.5 crore in June, seven…
Humanigen seeks EUA from USFDA for Lenzilumab to treat COVID-19 EP News Bureau May 30, 2021 This EUA application follows positive results from the LIVE-AIR Phase 3 clinical trial evaluating the ability of lenzilumab to…